SCHEMBL6180358

SCHEMBL6180358

CC(C)(C)OC(=O)Nc1cccc(OC(C)(C)C(=O)OCc2ccccc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 3/20 0.50
▸ PDK1 Q15118 1/20 0.47
▸ PDK2 Q15119 1/20 0.47
▸ PDK3 Q15120 1/20 0.47
▸ PDK4 Q16654 1/20 0.47
▸ ENPP2 Q13822 3/20 0.46
▸ RAB9A P51151 1/20 0.45
▸ AURKA O14965 1/20 0.44
▸ RPS6KB1 P23443 1/20 0.44
▸ PPARG P37231 2/20 0.44
▸ PPARA Q07869 2/20 0.44
▸ TOP2A P11388 1/20 0.44
▸ TOP2B Q02880 1/20 0.44
▸ BACE1 P56817 2/20 0.44
▸ PPARD Q03181 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ SYK P43405 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ KAT6A Q92794 1/20 0.42
▸ SIRT2 Q8IXJ6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2655891 0.86 PPARA (0.53) RAB9APPARGPPARACYP1A2
SCHEMBL22920172 0.83 PDK1 (0.65) MGLLPDK1PDK2PDK3PDK4
SCHEMBL29910262 0.83 PDK1 (0.65) MGLLPDK1PDK2PDK3PDK4
SCHEMBL6177506 0.82 PPARA (0.48) PDK1PDK2PDK3PDK4RAB9A
SCHEMBL7425443 0.79 RAB9A (0.71) MGLLENPP2RAB9ACYP1A2KAT6A
SCHEMBL14090974 0.78 BACE1 (0.56) MGLLPPARGBACE1SYK
SCHEMBL6178916 0.77 MAOB (0.52) PPARGPPARAPPARD
SCHEMBL28321345 0.77 MGLL (0.52) MGLLENPP2RAB9APPARGPPARA
SCHEMBL7043026 0.77 POLB (0.62) MGLLENPP2RAB9ATOP2ATOP2B
SCHEMBL4032867 0.76 NPC1 (0.57) PDK1PDK2PDK3PDK4RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 — — EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 — — EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 — — US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 — — EP disclosed
Send feedback